459 related articles for article (PubMed ID: 26882543)
1. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2.
Liu X; Tan Y; Zhang C; Zhang Y; Zhang L; Ren P; Deng H; Luo J; Ke Y; Du X
EMBO Rep; 2016 Mar; 17(3):349-66. PubMed ID: 26882543
[TBL] [Abstract][Full Text] [Related]
2. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity.
Li Q; Liu X; Jin K; Lu M; Zhang C; Du X; Xing B
BMC Cancer; 2017 Aug; 17(1):605. PubMed ID: 28859621
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression.
Deng M; Zhang L; Zheng W; Chen J; Du N; Li M; Chen W; Huang Y; Zeng N; Song Y; Chen Y
J Exp Clin Cancer Res; 2023 Jan; 42(1):9. PubMed ID: 36609449
[TBL] [Abstract][Full Text] [Related]
4. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress.
Xie N; Ma L; Zhu F; Zhao W; Tian F; Yuan F; Fu J; Huang D; Lv C; Tong T
Sci Rep; 2016 Nov; 6():36171. PubMed ID: 27811966
[TBL] [Abstract][Full Text] [Related]
6. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
Chen H; Han L; Tsai H; Wang Z; Wu Y; Duo Y; Cao W; Chen L; Tan Z; Xu N; Huang X; Zhuang J; Huang L
Oncotarget; 2016 Dec; 7(50):83241-83257. PubMed ID: 27829214
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.
Zhao K; Yang Y; Zhang G; Wang C; Wang D; Wu M; Mei Y
EMBO Rep; 2018 Feb; 19(2):305-319. PubMed ID: 29295817
[TBL] [Abstract][Full Text] [Related]
8. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
9. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
[TBL] [Abstract][Full Text] [Related]
10. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
[TBL] [Abstract][Full Text] [Related]
11. Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53.
Reed SM; Hagen J; Tompkins VS; Thies K; Quelle FW; Quelle DE
Cell Cycle; 2014; 13(8):1288-98. PubMed ID: 24621507
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.
Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X
J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424
[TBL] [Abstract][Full Text] [Related]
13. TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation.
Maeda R; Tamashiro H; Takano K; Takahashi H; Suzuki H; Saito S; Kojima W; Adachi N; Ura K; Endo T; Tamura TA
J Biol Chem; 2017 Feb; 292(8):3201-3212. PubMed ID: 28082682
[TBL] [Abstract][Full Text] [Related]
14. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
15. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
[TBL] [Abstract][Full Text] [Related]
16. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
[TBL] [Abstract][Full Text] [Related]
17. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor tyrosine kinase substrate enhances low levels of MDM2-mediated p53 ubiquitination.
Wang KS; Chen G; Shen HL; Li TT; Chen F; Wang QW; Wang ZQ; Han ZG; Zhang X
PLoS One; 2011; 6(8):e23571. PubMed ID: 21887275
[TBL] [Abstract][Full Text] [Related]
19. Deacetylation of NAT10 by Sirt1 promotes the transition from rRNA biogenesis to autophagy upon energy stress.
Liu X; Cai S; Zhang C; Liu Z; Luo J; Xing B; Du X
Nucleic Acids Res; 2018 Oct; 46(18):9601-9616. PubMed ID: 30165671
[TBL] [Abstract][Full Text] [Related]
20. Competitive ubiquitination activates the tumor suppressor p53.
Li X; Guo M; Cai L; Du T; Liu Y; Ding HF; Wang H; Zhang J; Chen X; Yan C
Cell Death Differ; 2020 Jun; 27(6):1807-1818. PubMed ID: 31796886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
